Calcitonin Gene-Related Peptide (CGRP) Antagonists and Their Use in Migraines

被引：7

作者：

Henson, Brianna ^{[1
]}

Hollingsworth, Hanna ^{[2
]}

Nevois, Erika ^{[3
]}

Herndon, Chris ^{[4
]}

机构：

[1] Wake Forest Baptist Hlth Brenner Childrens Hosp, Winston Salem, NC USA

[2] Parkland Hlth & Hosp Syst, Dallas, TX USA

[3] CVS Pharm, Springfield, IL USA

[4] Southern Illinois Univ Edwardsville, Sch Pharm, 200 Univ Pk Dr, Edwardsville, IL 62026 USA

来源：

JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY | 2020年 / 34卷 / 01期

关键词：

CGRP; migraine; calcitonin gene-related peptide; erenumab; galcanezumab; fremanezumab; DOUBLE-BLIND; EPISODIC MIGRAINE; RECEPTOR ANTAGONISTS; PREVENTIVE TREATMENT; EFFICACY; SAFETY; ANTIBODY; PHASE-2; TRIAL;

D O I：

10.1080/15360288.2019.1690616

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

Migraine is highly prevalent and associated with a large socio-economic burden in the United States. Current preventive medications have variable efficacy and their use is often limited by intolerable side effects. Calcitonin gene-related peptide (CGRP) has been identified as an integral part of migraine pathophysiology. There are currently seven CGRP antagonists under investigation, all of which are undergoing or have completed phase 3 clinical trials. Three of the investigated CGRP antagonists are approved for use within and outside of the United States. The trials have resulted in positive efficacy and safety data. The purpose of this review is to evaluate the seven CGRP antagonists and their future place in therapy.

引用

页码：22 / 31

页数：10

共 50 条

[1] Calcitonin gene-related peptide (CGRP) monoclonal antibodies for migraine
Giffin, Nicola J.
PRACTICAL NEUROLOGY, 2023, 23 (03) : 200 - +
[2] Calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraines in adults
Ocheretyaner, Eric R.
Kofman, Maria
Quattrocchi, Elaena
DRUGS IN CONTEXT, 2022, 11
[3] History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment
Tepper, Stewart J.
HEADACHE, 2018, 58 : 238 - 275
[4] Preparation of imidazoles as potent calcitonin gene-related peptide (CGRP) antagonists
Tora, George
Degnan, Andrew P.
Conway, Charles M.
Kostich, Walter A.
Davis, Carl D.
Pin, Sokhom S.
Schartman, Richard
Xu, Cen
Widmann, Kimberly A.
Macor, John E.
Dubowchik, Gene M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (20) : 5684 - 5688
[5] New drugs targeting calcitonin gene-related peptide for the management of migraines
Tana, Claudio
Cipollone, Francesco
Giamberardino, Maria Adele
Martelletti, Paolo
EXPERT OPINION ON EMERGING DRUGS, 2023, 28 (04) : 233 - 240
[6] Calcitonin Gene-Related Peptide Antagonists as a Savior in Episodic and Chronic Migraine: A Review
Pervez, Hira
Khemani, Lavina
Khan, Mahrukh A.
Seedat, Ahmed M.
Roshan, F. N. U.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
[7] Lipidated Calcitonin Gene-Related Peptide (CGRP) Peptide Antagonists Retain CGRP Receptor Activity and Attenuate CGRP Action In Vivo
Jamaluddin, Aqfan
Chuang, Chia-Lin
Williams, Elyse T.
Siow, Andrew
Yang, Sung Hyun
Harris, Paul W. R.
Petersen, Jakeb S. S. M.
Bower, Rebekah L.
Chand, Shanan
Brimble, Margaret A.
Walker, Christopher S.
Hay, Debbie L.
Loomes, Kerry M.
FRONTIERS IN PHARMACOLOGY, 2022, 13
[8] Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting
Wattiez, Anne-Sophie
Sowers, Levi P.
Russo, Andrew F.
EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (02) : 91 - 100
[9] Peptide Antagonists of the Calcitonin Gene-Related Peptide (CGRP) Receptor With Improved Pharmacokinetics and Pharmacodynamics
Miranda, Les P.
Shi, Licheng
Holder, Jerry R.
Wright, Marie
Gegg, Colin V.
Johnson, Eileen
Wild, Kenneth
Stenkilsson, Michael
Doellgast, George
Manning, Barton H.
Salyers, Kevin
BIOPOLYMERS, 2013, 100 (04) : 422 - 430
[10] Calcitonin Gene-Related Peptide (CGRP)-Targeted Treatments-New Therapeutic Technologies for Migraine
Sangalli, Linda
Brazzoli, Stefania
FUTURE PHARMACOLOGY, 2023, 3 (01): : 117 - 131

← 1 2 3 4 5 →